Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Insights - The company, Guangxun Technology, is a leading domestic optical communication enterprise with a vertical integration capability from chip to subsystem, benefiting from the growth of AI computing power in China [1][14] - The demand for high-speed optical modules is surging due to the increasing investment in AI infrastructure by global cloud service providers (CSPs) [2] - The company has a strong market position in the domestic market and is actively expanding into overseas markets, with a significant increase in net profit and revenue expected in the coming years [3][4] Summary by Sections Company Overview - Guangxun Technology has over 50 years of experience in the optical communication field, achieving vertical integration of optical devices through both organic growth and acquisitions [14][15] - The company has a diverse product line that includes optical transceivers, active optical cables, optical amplifiers, and subsystems, widely used in backbone networks, metropolitan networks, access networks, and data centers [19][24] Financial Performance - The company reported a net profit of 347 million yuan for Q3 2025, a year-on-year increase of 35.42% and a quarter-on-quarter increase of 56.00%, marking a historical high [1] - Revenue for 2025 is projected to reach 116.81 billion yuan, with net profits expected to be 10.60 billion yuan, reflecting a significant growth trajectory [3][4] Market Trends - The global AI computing power market is experiencing high demand, with CSPs expected to increase their capital expenditures significantly, which will drive the demand for optical modules [2][49] - The "East Data West Computing" initiative and the development of intelligent computing centers are expected to further boost the demand for transmission networks [2] Technology and Innovation - The company has developed its own optical chips and is expanding production capacity, with plans to raise 3.5 billion yuan for the development of high-speed optical transmission products [3][26] - Guangxun Technology is actively investing in new technologies such as CPO/OCS to lead the upgrade of optical interconnection technology [3][24] Competitive Position - The company ranks fourth globally in the optical device industry and has a leading market share in transmission networks, access networks, and data communication [1][2] - Guangxun Technology's products are increasingly being adopted in both domestic and international markets, with overseas revenue accounting for approximately 25% as of mid-2025 [26][29]

Investment Rating - The investment rating for the company is "Outperform the Market" [7] Core Views - The refining profit is expected to recover, with sulfur providing incremental performance [1] - The supply-demand relationship for PX continues to improve, and profitability in the polyester segment is likely to recover [2] - The company benefits from the increase in gasoline and diesel crack spreads due to overseas refinery disruptions [3] - Significant increases in sulfur prices provide profit elasticity for the company [4] - The company is positioned for substantial profit recovery from 2025 to 2027, with projected net profits of 1.38 billion, 2.27 billion, and 2.57 billion yuan respectively [4] Summary by Sections Company Overview - The company is a leading private refining and chemical enterprise in China, with a processing capacity of 40 million tons of crude oil and significant production capabilities in PX and PTA [1][18] - The company has a diversified product range, including high-end materials and new energy products, with ongoing projects expected to launch between 2026 and 2027 [1][18] Market Dynamics - The domestic PX capacity is expected to see minimal expansion from 2024 to 2025, while downstream PTA and polyester capacities are projected to grow, enhancing PX pricing power [2] - Global gasoline and diesel crack spreads have surged due to disruptions in overseas refineries, benefiting the company's refined oil exports [3] Financial Performance - The company achieved a revenue of 227.81 billion yuan in the first three quarters of 2025, with a slight year-on-year decline of 7.09%, but a net profit increase of 1.34% [39] - The projected net profits for 2025-2027 indicate a significant recovery trajectory, with a 90.9% increase expected in 2025 [4][11] Future Outlook - The company is focusing on high-quality development, with strategic investments in new materials and partnerships with major players like Saudi Aramco [28][34] - The ongoing projects in high-end materials and new energy are expected to enhance the company's product chain and profitability in the coming years [28][29]

Investment Rating - The report maintains an "Outperform" rating for the industry [1] Core Insights - The report emphasizes the importance of systematically researching next-generation innovative drugs for resistant hypertension (rHTN), highlighting that multiple new mechanism antihypertensive drugs will read out data and/or achieve clinical progress by 2025 [2] - Key catalysts include upcoming Phase 3 clinical studies focusing on cardiovascular and renal endpoints, which are expected to provide significant data in the coming years [2] - The report suggests paying attention to domestic companies involved in relevant target areas [2] Summary by Sections 01 Current Status and Unmet Needs in Hypertension Treatment - Hypertension is a prevalent cardiovascular disease, with approximately 90%-95% of patients suffering from primary hypertension, driven by factors such as salt sensitivity and obesity [3] - In the US, the prevalence of hypertension is around 48%, corresponding to approximately 120 million people, with about 60 million receiving antihypertensive treatment [3] - In China, the prevalence among adults aged 18 and older was 27.5% in 2018, with awareness, treatment, and control rates at 51.6%, 45.8%, and 16.8%, respectively [3] 02 Next-Generation Drug Focus on AGT and ASI - The report discusses the focus on AGT (Angiotensinogen) and ASI (Angiotensin II receptor blockers) in the development of next-generation antihypertensive drugs [3] - AGT-targeting drugs, particularly siRNA and ASO therapies, are highlighted as promising avenues for reducing blood pressure effectively [27] 03 Investment Recommendations - The report suggests that the market for resistant hypertension treatments is highly structured, with a focus on balancing efficacy and safety in drug development [16] - It emphasizes the need for drugs that can manage long-term adherence and safety, particularly for patients with comorbidities such as CKD and HF [19]

Report Industry Investment Rating No information provided in the content. Core Viewpoints of the Report - From December 22 - 26, the A - share market was active with continuous gains for five days. The commercial aerospace and precious metals sectors performed well. The bond market was weak on Monday but improved on Tuesday, with the 10 - year Treasury bond rate at 1.84% on Friday, up 0.68bp from the previous week. The convertible bond market was strong, with the CSI Convertible Bond Index rising 1.64% and the price median increasing 1.52%. [1][7][8] - From December 29 - 31, the convertible bond market was still strong, with the CSI Convertible Bond Index hitting a new high. The market price median was close to the August high, and the premium rates in all price - range convertible bonds were above the 95% historical percentile. In the future, the convertible bond market has support from the expected spring rally and institutional buying, but risks from annual report disclosures and high - gain hot - topic bonds should be noted. [3][17] Summary by Related Catalogs Market Focus (December 22 - 26) Stock Market - The A - share market had five consecutive days of gains. The commercial aerospace sector was boosted by policies and industry development, and precious metals were strong. The trading volume increased, and different sectors were active on different days. By industry, most Shenwan primary industries rose, with non - ferrous metals, national defense and military industry leading, and beauty care, social services lagging. [7][8] Bond Market - On Monday, the bond market was weak due to the disappointment of LPR cut expectations and the strong equity market. On Tuesday, Treasury bond futures and spot bonds improved. The central bank's Q4 monetary policy meeting had little impact. The 10 - year Treasury bond rate closed at 1.84% on Friday, up 0.68bp from the previous week. [1][7][8] Convertible Bond Market - Most convertible bond issues rose. The CSI Convertible Bond Index rose 1.64%, the price median increased 1.52%, and the arithmetic average parity increased 2.42%. The overall conversion premium rate decreased by 0.21%. By industry, national defense and military industry, building materials led in gains, while commercial retail, beauty care led in losses. In terms of individual bonds, Jiamei, Zai 22, etc. had large gains, while Huati, Saili, etc. had large losses. The total trading volume was 3928.17 billion yuan, with an average daily volume of 785.63 billion yuan, higher than the previous week. [2][8][11] Views and Strategies (December 29 - 31) - The convertible bond market was strong last week, with the CSI Convertible Bond Index hitting a new high. The market price median was close to the August high, and the premium rates in all price - range convertible bonds were at high historical levels. [3][17] - In the future, the convertible bond market has support from the expected spring rally and institutional buying in January. However, in January, with the annual report disclosures and high - gain hot - topic bonds, some individual bonds with performance pressure may face challenges. [3][17] - Currently, the convertible bond market valuation is at a historical high, and overall opportunities are scarce. Relative - return investors are advised to allocate small - position, well - balanced non - redeemable and appropriately - priced equity - biased convertible bonds in sectors such as power, storage, etc. Absolute - return investors are advised to focus on high - volatility underlying stocks below 130 yuan or industry leaders with historically low valuations. [3][17] Valuation Overview - As of December 26, the average conversion premium rates of equity - biased convertible bonds in different price ranges were at high historical percentile levels. The average YTM of debt - biased convertible bonds with a parity below 70 yuan was - 4.44%, at a low historical percentile. The average implied volatility of all convertible bonds was 44.43%, at a high historical percentile, and the difference between the convertible bond implied volatility and the long - term actual volatility of the underlying stock was 3.3%, also at a high historical percentile. [18] Primary Market Tracking Last Week (December 22 - 26) - Shuangle Convertible Bond and Jin 05 Convertible Bond announced issuance, and Pulan Convertible Bond was listed. Shuangle Convertible Bond is from the basic chemical industry, with an issue size of 800 million yuan. Jin 05 Convertible Bond is from the power equipment industry, with an issue size of 1.672 billion yuan. Pulan Convertible Bond is from the computer industry, with an issue size of 243 million yuan. [25][26][27] Next Week (December 29 - 31) - Tianzhun Convertible Bond and Shenyu Convertible Bond are expected to be listed. Tianzhun Convertible Bond is from the machinery and equipment industry, with an issue size of 872 million yuan. Shenyu Convertible Bond is from the communication industry, with an issue size of 500 million yuan. [29][30] Overall Situation - As of December 26, there are currently 93 convertible bonds to be issued, with a total scale of 146.86 billion yuan. Among them, 3 issues with a total scale of 3.43 billion yuan have been approved for registration, and 10 issues with a total scale of 8.52 billion yuan have passed the listing committee. [31]

Report Industry Investment Rating - The investment rating for the US dollar bond industry is "Underperform the Market" [1][4] Core Viewpoints - US employment data continues to cool, with weak employment growth and a rising unemployment rate. In November, non - farm payrolls increased by about 64,000, and the unemployment rate rose unexpectedly to 4.6%, the highest since September 2021. In October, non - farm data weakened significantly, with a decrease of 105,000 jobs [1] - Inflation data unexpectedly cooled. The US CPI in November rose 2.7% year - on - year, and the core CPI rose only 2.6% year - on - year, the lowest since 2021, providing room for interest rate cut expectations next year [2] - The US GDP in the third quarter grew at an annualized quarterly rate of 4.3%, the fastest in two years, mainly driven by consumer and business spending resilience and more stable trade policies [2] - In the US dollar bond market, it is recommended to prioritize defense. Corely allocate medium - and short - duration investment - grade bonds (5 - 7 - year investment - grade bonds currently have a yield of about 4.3%) and moderately allocate TIPS while keeping low allocations for long - duration varieties over 10 years [3] Summary by Related Catalogs 1. US Macro - economy and Liquidity - Employment: US employment data shows a cooling trend. In November, non - farm payrolls increased slightly, and the unemployment rate reached a new high. In October, non - farm data was significantly weak, affected by the sharp reduction in federal government employment [1] - Inflation: The US CPI and core CPI in November showed significant cooling, providing room for future monetary policy adjustments and interest rate cut expectations next year [2] - GDP: The US GDP in the third quarter grew at an annualized quarterly rate of 4.3%, the fastest in two years, with strong consumer and business spending [2] 2. Exchange Rate - The report presents multiple figures related to non - US currency trends, Sino - US sovereign bond spreads, and the relationship between the US dollar index and other indicators, but no specific analysis content about exchange rates is provided [50][55][57] 3. Chinese - funded US Dollar Bonds - The report shows figures such as the return trends of Chinese - funded US dollar bonds since 2023 (by level and industry), the yield and spread trends of investment - grade and high - yield Chinese - funded US dollar bonds, and the returns in the past two weeks (by level and industry), but no specific analysis content is provided [63][65][67] 4. Rating Actions - In the past two weeks, the three major international rating agencies took 16 rating actions on Chinese - funded US dollar bond issuers, including 2 rating revocations, 6 rating upgrades, 5 rating downgrades, and 3 initial ratings. Specific rating actions for each issuer are listed in the table [71][72]

Investment Rating - The investment rating for the company is "Outperform the Market" [7] Core Views - The refining profit is expected to recover, with sulfur providing incremental performance [1] - The supply-demand relationship for PX continues to improve, and profitability in the polyester segment is likely to recover [2] - The company benefits from the increase in gasoline and diesel crack spreads due to overseas refinery disruptions [3] - Significant price increases in sulfur are expected to enhance the company's profit margins [4] - The company is positioned for substantial profit recovery from 2025 to 2027, with projected net profits of 1.38 billion, 2.27 billion, and 2.57 billion yuan respectively, reflecting growth rates of 90.9%, 64.2%, and 13.1% [4] Summary by Sections Company Overview - The company is a leading private refining and chemical enterprise in China, with a processing capacity of 40 million tons of crude oil and significant production capabilities in PX and PTA [1][18] - The company has a diverse product range, including high-end materials and new energy products, with ongoing projects expected to launch between 2026 and 2027 [1][18] Market Dynamics - The domestic PX capacity is expected to see minimal expansion from 2024 to 2025, while downstream PTA and polyester capacities are projected to grow, improving the supply-demand balance [2] - Global gasoline and diesel crack spreads have surged due to disruptions in overseas refineries, benefiting the company's export capabilities [3] Financial Projections - The company anticipates a significant recovery in profitability, with net profit forecasts showing substantial growth over the next three years [4][11] - Revenue from chemical products, refining, PTA, and polyester films is expected to contribute significantly to the company's overall income, with stable margins in the refining segment [21][39] Strategic Initiatives - The company is focusing on enhancing its product chain through investments in high-end materials and new energy sectors, aiming for a comprehensive industrial layout [1][28] - The introduction of strategic investors like Saudi Aramco is expected to bolster the company's long-term growth prospects [34][28]

证券研究报告 | 2025年12月28日 2025年12月29日 可交换私募债跟踪 私募 EB 每周跟踪（20251222-20251226） 固定收益快评 | 证券分析师： | 王艺熹 | 021-60893204 | wangyixi@guosen.com.cn | 执证编码：S0980522100006 | | --- | --- | --- | --- | --- | | 证券分析师： | 吴越 | 021-60375496 | wuyue8@guosen.com.cn | 执证编码：S0980525080001 | | 证券分析师： | 赵婧 | 0755-22940745 | zhaojing@guosen.com.cn | 执证编码：S0980513080004 | 项目获批进度不及预期，经济增速下滑 请务必阅读正文之后的免责声明及其项下所有内容 1 证券研究报告 表1：私募 EB 每周跟踪(2025-12-26） | 债券名称 | 主承销商 | 规模 | 标的股票 | 项目状态 | 更新日期 | | --- | --- | --- | --- | --- | --- | | 南山集团有限公司 ...

证券研究报告 | 2025年12月29日 | 晨会纪要 | | --- | | 数据日期:2025-12-26 | 上证综指 | 深证成指沪深 | 300 指数 | 中小板综指 | 创业板综指 | 科创 50 | | --- | --- | --- | --- | --- | --- | --- | | 收盘指数（点） | 3963.67 | 13603.89 | 4657.24 | 14573.33 | 3934.70 | 1345.82 | | 涨跌幅度（%） | 0.10 | 0.53 | 0.31 | 0.38 | -0.09 | -0.23 | | 成交金额（亿元） | 8936.44 | 12665.47 | 4604.26 | 4672.38 | 5713.13 | 451.90 | $\frac{\pi\times6}{\pi\times6}$. 【重点推荐】 行业与公司 建筑行业快评:洁净室工程点评-为何洁净室能成为 AI 基建主线？ 华图山鼎(300492.SZ) 深度报告:公考热下竞争格局重塑，产品创新抢占 成长先机 【常规内容】 宏观与策略 宏观周报:宏观经济周报-当基期调整遇上价格回 ...

《生物安全法案》复盘 --如何看待地缘政治对中国CXO企业的影响？ 行业研究 · 行业专题 医药生物 · 医疗研发外包 投资评级：优于大市（维持评级） 0755-81982723 pengsiyu@guosen.com.cn S0980521060003 证券分析师：陈曦炳 0755-81982939 chenxibing@guosen.com.cn S0980521120001 证券分析师：彭思宇 证券分析师：凌珑 021-60375401 linglong@guosen.com.cn S0980525070003 请务必阅读正文之后的免责声明及其项下所有内容 1 报告摘要 证券研究报告 | 2025年12月28日 n 靴子落地，美国《2026财年国防授权法案》夹带《生物安全法案》生效。 请务必阅读正文之后的免责声明及其项下所有内容 2 ü 《2026财年国防授权法案》夹带《生物安全法案》（主要指第851节《禁止与特定生物技术公司签订合同》）落地，标志着美国已将生物安全正式纳入国家防务与 安全战略框架统筹考量，同时彰显其在生物技术供应链自主可控的明确政策转向，本质是中美的科技竞争与产业安全博弈在生物领域的延 ...

证券研究报告 | 2025年12月28日 基金周报 中国 ETF 市场总规模突破 6 万亿，基金销售子公司再迎扩容 核心观点 金融工程周报 上周市场回顾。上周 A 股市场主要宽基指数全线上涨，中证 500、创业 板指、中小板指收益靠前，收益分别为 4.03%、3.90%、3.88%，上证 综指、沪深 300、科创 50 收益靠后，收益分别为 1.88%、1.95%、2.85%。 从成交额来看，上周主要宽基指数成交额均有所上升。行业方面，上周 有色金属、国防军工、基础化工收益靠前，收益分别为 6.45%、6.39%、 5.41%，商贸零售、银行、煤炭收益靠后，收益分别为-1.31%、-0.89%、 -0.89%。 截至上周五，央行逆回购净回笼资金 348 亿元，逆回购到期 4575 亿元， 净公开市场投放 4227 亿元。除 10 年期外，不同期限的国债利率均有所 下行，利差扩大 7.43BP。 上周共上报 77 只基金，较上上周申报数量有所增加。申报的产品包括 1 只 REITs，2 只 QDII，8 只 FOF，易方达中证全指红利质量 ETF、前海 开源上证科创板 100ETF、天弘创业板新能源 ETF、鹏 ...